Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)

INTRODUCTION: Quantitative benefit-risk models (qBRm) applied to vaccines are increasingly used by public health authorities and pharmaceutical companies as an important tool to help decision makers with supporting benefit-risk assessment (BRA). However, many publications on vaccine qBRm provide ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Arlegui, Hugo, Bollaerts, Kaatje, Bauchau, Vincent, Nachbaur, Gaëlle, Bégaud, Bernard, Praet, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486804/
https://www.ncbi.nlm.nih.gov/pubmed/32918682
http://dx.doi.org/10.1007/s40264-020-00982-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486804/
https://www.ncbi.nlm.nih.gov/pubmed/32918682
http://dx.doi.org/10.1007/s40264-020-00982-9

Ejemplares similares